Raday Gilead sold $1K of RDHL

U.S. stocks ended the week lower, with the Dow down 1.93%, S&P 500 down 1.25%, and Nasdaq down 0.90%. The Russell 2000 underperformed, falling 1.16%. The 10-year Treasury yield rose 6 basis points to 5.24%. Earnings reports from McCormick (MKC), Conagra (CAG), Recon Technology (RCON), Yiren Digital (YRD), and RedHill Biopharma (RDHL) were released.

RedHill Biopharma Ltd. (RDHL) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 ​ ​ Press Release RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results ​ Executing a full strategic portfolio reset, RedHill is now a stronger commercial entity with Rebyota ® and Clenpiq ® , two established FDA-approved gastrointe

RedHill Biopharma (RDHL) shares surged 58.85% to $1.60 after selling its 70% stake in Talicia to Apotex for $18M upfront and up to $35M in milestones. The deal strengthens RedHill's liquidity and funds expansion, according to the company.

RedHill Biopharma (RDHL) shares rose 64% after announcing the sale of its Talicia business to Apotex Health Corp. for $18M upfront and up to $35M in milestones. The stock traded at $1.08, up from a 52-week low of $0.57.

Pale Fire Capital SE purchased 648,356 indirectly-held shares of Dole plc (DOLE) at an average of $13.19 ($13.12–$13.39, $8.55M total) across 3 trades over 2026-10-20 to 2026-10-22. Filed jointly with Pale Fire Capital SICAV a.s. (10% owner), Pale Fire Capital investicni spolecnost a.s. (10% owner), Senkypl Dusan (10% owner) and Barta Jan (10% owner).

INGRAM ORRIN H II purchased 29,081 shares of FB Financial Corp (FBK) at an average of $52.88 ($52.68–$53.11, $1.54M total) across 2 trades on 2026-10-20.